Danshensu
CAS: 22681-72-7
Ref. 3D-FD73855
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Informação sobre produto
- 3,4-Dihydroxyphenyllactic Acid
- Benzeneacetic Acid, Alpha,3,4-Trihydroxy-Alpha-Methyl-
- Alpha-(3,4-Dihydroxyphenyl)Lactic Acid
Danshensu is an injection solution that can be used in the treatment of oxidative injury. It contains a mixture of salvia miltiorrhizae and p-hydroxybenzoic acid, which are natural products that have antioxidant effects. The antioxidant activity of Danshensu is related to its ability to scavenge free radicals and inhibit lipid peroxidation. Danshensu has been shown to improve myocardial infarct size by affecting energy metabolism and the concentration-time curve for polymerase chain reaction (PCR). This drug also has the potential to act as a matrix effect enhancer, which could be useful for PCR reactions performed under constant pressure. Danshensu also has anti-inflammatory activities that may be due to its production of growth factor-β1, which inhibits proinflammatory cytokine production.
Propriedades químicas
Consulta técnica sobre: 3D-FD73855 Danshensu
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
